Rats and zebrafish treated with OKA develop distinct hallmarks of AD, which include β-amyloid plaques, tau aggregates/tangles, increased expression of kinase glycogen synthase 3β (GSK-3β), and impairment of learning and memory [20,22,23,24]. Here, MAPT is linked to Alzheimer disease.